Keywords: Actelion, Second-quarter 2011 financial results
Actelion reports bigger-than-expected 2nd-qtr 2011 loss
Article | 22 July 2011
Switzerland-based Actelion (ATLN: VX) reported first-half 2011 results with 8% (local currency) growth in total net revenues to CHF 969.9 million Swiss francs ($1.19 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
